Granahan Investment Management, LLC Intercept Pharmaceuticals, Inc. Transaction History

Granahan Investment Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$24.48 - $42.47 $1.09 Million - $1.9 Million	-44,625 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$39.09 - $53.44 $223,477 - $305,516	-5,717 Reduced 11.36%	44,625 $1.85 Million
Q2 2020 Aug 14, 2020	BUY	$46.7 - $92.04 $10,787 - $21,261	231 Added 0.46%	50,342 $2.41 Million
Q1 2020 May 12, 2020	BUY	$48.35 - $118.68 $725 - $1,780	15 Added 0.03%	50,111 $3.16 Million
Q4 2019 Feb 14, 2020	SELL	$57.36 - $124.1 $107,377 - $232,315	-1,872 Reduced 3.6%	50,096 $6.21 Million
Q3 2019 Nov 15, 2019	BUY	$58.69 - $80.46 $214,981 - $294,724	3,663 Added 7.58%	51,968 $3.45 Million
Q2 2019 Aug 14, 2019	SELL	$77.77 - $120.68 $344,909 - $535,215	-4,435 Reduced 8.41%	48,305 $3.84 Million
Q1 2019 May 14, 2019	BUY	$91.83 - $120.68 $4.84 Million - $6.36 Million	52,740 New	52,740 $5.9 Million

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Granahan Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Granahan Investment Management, LLC with notifications on news.